A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of MEDI-546 in Adults With Systemic Lupus Erythematosus
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008196/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the long-term safety of anifrolumab (MEDI-546) in
adults with moderate to severe active systemic lupus erythematosus (SLE).
提供机构：
Vivli
创建时间：
2022-07-06
